Lessons from long-term survey of stage I NSCLC

Editor's Choice for June 2018

ASCO 2018 conference round up

Treating CLL with obinutuzumab

First in-human trial of AMV564 for AML

SETBP1 induces transcription of developmental genes

Combination therapy for CLL in the CAPTIVATE trial

Efficacy of novel agents in r/r T pro-lymphocytic leukaemia

Isatuximab in combination to treat relapsed/refractory MM

Development of a risk stratifying prognostic index for ALL

Specification of haematopoetic stem cell fate via modulation of mitochondrial activity

Onset and treatment of infantile leukaemia